TRPV1 and cancer: Thus, slight potentiation of TRPV1-dependent contractility of isolated DSM strips from cancerous bladder would be indicative of enhanced “efferent” function of TRPV1-expressing bladder afferents due to release of pro-contractile tachykinins in response to TRPV1 activation25.